Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology
Seminars in Cancer Biology · 2023
DOI: 10.1016/j.semcancer.2023.02.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023. Verfasst von Jun Shao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Med-X Center for Manufacturing, Institute of Respiratory Health, Frontiers Science Center for D…. Hauptthemen laut MEDLINE: Artificial Intelligence, Neoplasms. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Med-X Center for Manufacturing, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, West China Scho…
- AI Lab, Deepwise Healthcare, Beijing 100080, China.
- Department of Postgraduate Student, West China Hospital, West China School of Medicine, Sichuan University, No. 37 GuoXue Alley, Chengdu 610041, China.
Zitieren
APA
Shao, J., Ma, J., Zhang, Q., Li, W., & Wang, C. (2023). Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2023.02.006
Vancouver
Shao J, Ma J, Zhang Q, Li W, Wang C. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology. Seminars in Cancer Biology. 2023. doi:10.1016/j.semcancer.2023.02.006
BibTeX
@article{Shao2023,
author = {Shao, Jun and Ma, Jiechao and Zhang, Qin and Li, Weimin and Wang, Chengdi},
title = {Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology},
journal = {Seminars in Cancer Biology},
year = {2023},
doi = {10.1016/j.semcancer.2023.02.006}
}
EUVIMED